[
    {
        "text": "Thank you to Magic Spoon for sponsoring today’s\nepisode!",
        "start": 0.19,
        "duration": 2.54
    },
    {
        "text": "Go to magicspoon.com/SciShow",
        "start": 2.73,
        "duration": 2.04
    },
    {
        "text": "and use the code SciShow at checkout to get\n$5 off any order.",
        "start": 4.77,
        "duration": 2.85
    },
    {
        "text": "[♪ INTRO]",
        "start": 7.62,
        "duration": 4.339
    },
    {
        "text": "Creating a new medication takes years, and\nsometimes decades, of work.",
        "start": 11.959,
        "duration": 4.301
    },
    {
        "text": "Sotorasib, a recently approved lung cancer\ndrug,",
        "start": 16.26,
        "duration": 2.29
    },
    {
        "text": "might seem super new,",
        "start": 18.55,
        "duration": 1.53
    },
    {
        "text": "but it has a story starting with research\nin the 80s.",
        "start": 20.08,
        "duration": 3.73
    },
    {
        "text": "Medications like sotorasib had to take a long,",
        "start": 23.81,
        "duration": 2.34
    },
    {
        "text": "difficult path through laboratory testing,\nclinical trials in people,",
        "start": 26.15,
        "duration": 3.76
    },
    {
        "text": "and evaluation and approval by regulatory\nagencies",
        "start": 29.91,
        "duration": 2.69
    },
    {
        "text": "before they reached doctors’ offices and\nstore shelves.",
        "start": 32.6,
        "duration": 3.389
    },
    {
        "text": "And once they’ve made that journey,",
        "start": 35.989,
        "duration": 1.44
    },
    {
        "text": "they can finally help patients.",
        "start": 37.429,
        "duration": 2.421
    },
    {
        "text": "Today, we want to peek behind the curtain\na bit",
        "start": 39.85,
        "duration": 2.229
    },
    {
        "text": "and look at one of the earliest phases of\ndrug research,",
        "start": 42.079,
        "duration": 3.53
    },
    {
        "text": "which can also feel the most secretive and\nmysterious:",
        "start": 45.609,
        "duration": 3.801
    },
    {
        "text": "research and development, or R&D.",
        "start": 49.41,
        "duration": 1.96
    },
    {
        "text": "We can see all of the areas of R&D in practice",
        "start": 51.37,
        "duration": 2.599
    },
    {
        "text": "by following the winding road to the creation\nof the medication sotorasib.",
        "start": 53.969,
        "duration": 4.27
    },
    {
        "text": "The U.S. Food and Drug Administration approved\nsotorasib in May 2021",
        "start": 58.239,
        "duration": 4.17
    },
    {
        "text": "for use under certain circumstances to treat\nlung cancer.",
        "start": 62.409,
        "duration": 3.491
    },
    {
        "text": "Specifically, it targets cancers caused by\na mutation in the gene KRAS,",
        "start": 65.9,
        "duration": 4.49
    },
    {
        "text": "which is linked to about a quarter of non-small\ncell lung cancer cases.",
        "start": 70.39,
        "duration": 4.16
    },
    {
        "text": "But first, we had to learn exactly what we\nwere dealing with.",
        "start": 74.55,
        "duration": 3.06
    },
    {
        "text": "So this medication’s journey to being created\nstarted decades earlier",
        "start": 77.61,
        "duration": 3.03
    },
    {
        "text": "with the first stage of R&D, the basic research\nphase.",
        "start": 80.64,
        "duration": 3.62
    },
    {
        "text": "See, R&D involves working to increase how\nmuch we know about a subject",
        "start": 84.26,
        "duration": 4.45
    },
    {
        "text": "and then finding new ways to apply that knowledge.",
        "start": 88.71,
        "duration": 2.99
    },
    {
        "text": "To be considered research and development,\nthat work needs to be new,",
        "start": 91.7,
        "duration": 3.3
    },
    {
        "text": "have a creative and planned approach, and\nbe reproducible by other people.",
        "start": 95.0,
        "duration": 4.17
    },
    {
        "text": "When it comes to scientific research,",
        "start": 99.17,
        "duration": 1.32
    },
    {
        "text": "those qualities apply to three stages:",
        "start": 100.49,
        "duration": 2.49
    },
    {
        "text": "First, basic research,",
        "start": 102.98,
        "duration": 1.66
    },
    {
        "text": "which seeks a foundational understanding of\nsomething,",
        "start": 104.64,
        "duration": 2.96
    },
    {
        "text": "applied research, which usually has a more\nspecific",
        "start": 107.6,
        "duration": 2.94
    },
    {
        "text": "or practical objective than basic research,",
        "start": 110.54,
        "duration": 2.19
    },
    {
        "text": "and experimental development,",
        "start": 112.73,
        "duration": 1.95
    },
    {
        "text": "which uses the basic and applied research",
        "start": 114.68,
        "duration": 2.01
    },
    {
        "text": "to create a new product or improve something\nthat’s already out there.",
        "start": 116.69,
        "duration": 3.46
    },
    {
        "text": "So, to start, we had to get a foundational\nunderstanding",
        "start": 120.15,
        "duration": 2.4
    },
    {
        "text": "of how the KRAS gene works a",
        "start": 122.55,
        "duration": 2.13
    },
    {
        "text": "nd how mutations of it can lead to cancer.",
        "start": 124.68,
        "duration": 2.45
    },
    {
        "text": "Our genes are written in the chemical code\nof life, DNA.",
        "start": 127.13,
        "duration": 3.08
    },
    {
        "text": "And when a cell needs to use a gene, it transcribes",
        "start": 130.21,
        "duration": 2.89
    },
    {
        "text": "and translates the code into another chemical,\namino acids.",
        "start": 133.1,
        "duration": 7.76
    },
    {
        "text": "For example, cells use the KRAS gene to build\nK-Ras proteins.",
        "start": 140.86,
        "duration": 4.61
    },
    {
        "text": "When there’s a mutation, or mistake, in\nthe DNA,",
        "start": 145.47,
        "duration": 2.82
    },
    {
        "text": "that can lead the cell to use the wrong amino\nacid when it’s building a protein.",
        "start": 148.29,
        "duration": 3.48
    },
    {
        "text": "About half of cancers linked to KRAS have\nG12C mutations.",
        "start": 151.77,
        "duration": 5.22
    },
    {
        "text": "That means that the twelfth amino acid in\nthe protein, which is normally glycine, is",
        "start": 156.99,
        "duration": 4.079
    },
    {
        "text": "replaced by cysteine.",
        "start": 161.069,
        "duration": 1.551
    },
    {
        "text": "And researchers have known about this mutation\nand its link to cancer for a long time.",
        "start": 162.62,
        "duration": 4.82
    },
    {
        "text": "KRAS was actually one of the first cancer-causing\ngenes,",
        "start": 167.44,
        "duration": 2.83
    },
    {
        "text": "or oncogenes, discovered in the early 1980s,",
        "start": 170.27,
        "duration": 2.43
    },
    {
        "text": "around the same time as HRAS and NRAS.",
        "start": 172.7,
        "duration": 2.42
    },
    {
        "text": "Each of these genes encodes a protein of the\nsame name.",
        "start": 175.12,
        "duration": 2.88
    },
    {
        "text": "As a group, they’re called “Ras proteins.”",
        "start": 178.0,
        "duration": 2.14
    },
    {
        "text": "Healthy Ras proteins spend a lot of time inactive,",
        "start": 180.14,
        "duration": 2.63
    },
    {
        "text": "not doing anything in the cell.",
        "start": 182.77,
        "duration": 2.04
    },
    {
        "text": "But a few supervisor proteins can activate\nthem, and when activated,",
        "start": 184.81,
        "duration": 3.76
    },
    {
        "text": "Ras proteins start directing lots of other\ncellular machinery",
        "start": 188.57,
        "duration": 3.2
    },
    {
        "text": "to make the cell grow and divide.",
        "start": 191.77,
        "duration": 2.19
    },
    {
        "text": "And You need your cells to multiply for you\nto grow,",
        "start": 193.96,
        "duration": 2.37
    },
    {
        "text": "heal after an injury, or just create new healthy\ncells to replace dead ones,",
        "start": 196.33,
        "duration": 3.87
    },
    {
        "text": "like dead skin.",
        "start": 200.2,
        "duration": 1.16
    },
    {
        "text": "Unfortunately, when KRAS gets a mutation like\nG12C,",
        "start": 201.36,
        "duration": 3.51
    },
    {
        "text": "the protein doesn’t listen to its supervisors\nanymore.",
        "start": 204.87,
        "duration": 3.37
    },
    {
        "text": "Almost as soon as it switches into its inactive\nstate, it flips back into its active state,",
        "start": 208.24,
        "duration": 5.6
    },
    {
        "text": "which results in a near-constant message for\nthe cell to grow.",
        "start": 213.84,
        "duration": 3.48
    },
    {
        "text": "And that uncontrolled cell growth is cancer.",
        "start": 217.32,
        "duration": 2.999
    },
    {
        "text": "Equipped with all of that basic research,\nscientists could move",
        "start": 220.319,
        "duration": 3.541
    },
    {
        "text": "on to the next phase: applied research.",
        "start": 223.86,
        "duration": 2.11
    },
    {
        "text": "There’s a clear goal: this mutated K-Ras\nprotein is causing cancer,",
        "start": 225.97,
        "duration": 4.239
    },
    {
        "text": "so they wanted to find a way to stop it.",
        "start": 230.209,
        "duration": 1.711
    },
    {
        "text": "In this case, they wanted to force the mutant\nG12C K-Ras protein",
        "start": 231.92,
        "duration": 3.65
    },
    {
        "text": "to stay in its inactive state by blocking\nit with a specially designed molecule,",
        "start": 235.57,
        "duration": 4.71
    },
    {
        "text": "kind of like jamming something into the gears\nof a machine to make it stop.",
        "start": 240.28,
        "duration": 3.56
    },
    {
        "text": "Researchers have a few factors in mind while\nsearching for the best drug to do the job.",
        "start": 243.84,
        "duration": 3.83
    },
    {
        "text": "For one thing, any drug molecule would need",
        "start": 247.67,
        "duration": 1.65
    },
    {
        "text": "to be as specific as possible to the mutant,",
        "start": 249.32,
        "duration": 2.75
    },
    {
        "text": "always-active version of the K-Ras protein.",
        "start": 252.07,
        "duration": 2.22
    },
    {
        "text": "You don’t want to accidentally jam the healthy\nRas proteins",
        "start": 254.29,
        "duration": 2.67
    },
    {
        "text": "and turn off cell division altogether.",
        "start": 256.96,
        "duration": 1.749
    },
    {
        "text": "And there was another challenge:",
        "start": 258.709,
        "duration": 1.361
    },
    {
        "text": "The G12C K-Ras protein is super, super smooth.",
        "start": 260.07,
        "duration": 3.87
    },
    {
        "text": "So smooth that it seemed like there was nowhere",
        "start": 263.94,
        "duration": 3.12
    },
    {
        "text": "for a drug molecule to latch on at all,",
        "start": 267.06,
        "duration": 2.43
    },
    {
        "text": "and therefore no way for it to slam on the\nbrakes.",
        "start": 269.49,
        "duration": 2.35
    },
    {
        "text": "This protein’s shape presented",
        "start": 271.84,
        "duration": 1.35
    },
    {
        "text": "such a challenge that scientists started to\ncall K-Ras “undruggable,”",
        "start": 273.19,
        "duration": 4.39
    },
    {
        "text": "and research and development stalled for decades.",
        "start": 277.58,
        "duration": 2.5
    },
    {
        "text": "Stalled, but did not stop.",
        "start": 280.08,
        "duration": 1.92
    },
    {
        "text": "In 2013, 30 years after the discovery of G12C\nK-Ras proteins,",
        "start": 282.0,
        "duration": 5.25
    },
    {
        "text": "researchers at the University of California,\nSan Francisco,",
        "start": 287.25,
        "duration": 3.0
    },
    {
        "text": "found molecules that could",
        "start": 290.25,
        "duration": 1.16
    },
    {
        "text": "slip into a small groove on the surface of\nmutant K-Ras proteins",
        "start": 291.41,
        "duration": 3.89
    },
    {
        "text": "that’s only visible when the protein is\nin its inactive form.",
        "start": 295.3,
        "duration": 3.82
    },
    {
        "text": "One molecule in particular, called Compound\n12,",
        "start": 299.12,
        "duration": 2.84
    },
    {
        "text": "holds really tightly to that small groove,\nstopping cells",
        "start": 301.96,
        "duration": 3.19
    },
    {
        "text": "from growing and instead causing cells to\ndie.",
        "start": 305.15,
        "duration": 3.25
    },
    {
        "text": "This works because the molecule uses the twelfth\namino acid in the mutant protein,",
        "start": 308.4,
        "duration": 4.45
    },
    {
        "text": "which is a cysteine, to attach to the protein\nand make it inactive.",
        "start": 312.85,
        "duration": 3.62
    },
    {
        "text": "And because the healthy K-Ras protein has\na glycine in that spot,",
        "start": 316.47,
        "duration": 3.44
    },
    {
        "text": "it should not be affected by the drug.",
        "start": 319.91,
        "duration": 2.31
    },
    {
        "text": "This discovery was great news.",
        "start": 322.22,
        "duration": 2.25
    },
    {
        "text": "But while finding this groove could be considered\nthe end of the applied research phase",
        "start": 324.47,
        "duration": 4.02
    },
    {
        "text": "it is not the end of the story.",
        "start": 328.49,
        "duration": 2.61
    },
    {
        "text": "Next was the experimental development phase,",
        "start": 331.1,
        "duration": 2.71
    },
    {
        "text": "and Compound 12 was just the starting point.",
        "start": 333.81,
        "duration": 2.6
    },
    {
        "text": "The goal of this phase was, and is, to find\na drug",
        "start": 336.41,
        "duration": 3.37
    },
    {
        "text": "that can both stop the mutant protein from\ncausing cancer",
        "start": 339.78,
        "duration": 2.7
    },
    {
        "text": "and leave cells with healthy proteins alone.",
        "start": 342.48,
        "duration": 2.939
    },
    {
        "text": "So researchers took that molecule, studied\nits shape, and iterated on it.",
        "start": 345.419,
        "duration": 3.891
    },
    {
        "text": "That means they tweaked it bit by bit",
        "start": 349.31,
        "duration": 2.04
    },
    {
        "text": "and tested their new versions against both\ncells",
        "start": 351.35,
        "duration": 2.38
    },
    {
        "text": "with mutated G12C K-Ras proteins and healthy\ncells,",
        "start": 353.73,
        "duration": 3.61
    },
    {
        "text": "all in petri dishes, to find the most specific\nand effective tool.",
        "start": 357.34,
        "duration": 3.96
    },
    {
        "text": "First, researchers at a company called Wellspring\nBiosciences",
        "start": 361.3,
        "duration": 2.86
    },
    {
        "text": "took a closer look at Compound 12.",
        "start": 364.16,
        "duration": 2.039
    },
    {
        "text": "They found that, even though Compound 12 sticks\nto the groove in the mutant protein,",
        "start": 366.199,
        "duration": 3.871
    },
    {
        "text": "it doesn’t substantially affect cells containing\nthem even after six hours of treatment.",
        "start": 370.07,
        "duration": 4.849
    },
    {
        "text": "So the researchers made changes to Compound\n12’s individual parts.",
        "start": 374.919,
        "duration": 3.78
    },
    {
        "text": "kind of like swapping out parts of a multitool,\nbut instead of a screwdriver or a tiny pair",
        "start": 378.699,
        "duration": 4.041
    },
    {
        "text": "of scissors, each subunit is a collection\nof atoms.",
        "start": 382.74,
        "duration": 3.05
    },
    {
        "text": "By changing around several of those submolecular\nparts",
        "start": 385.79,
        "duration": 3.189
    },
    {
        "text": "and measuring how they interacted with the\nmutant protein’s groove,",
        "start": 388.979,
        "duration": 3.711
    },
    {
        "text": "they came up with a molecule that could lock\nthe mutated protein",
        "start": 392.69,
        "duration": 3.06
    },
    {
        "text": "into the inactive state and stop it from telling\nthe cell to grow.",
        "start": 395.75,
        "duration": 3.669
    },
    {
        "text": "They dubbed their new molecule “ARS-853.”",
        "start": 399.419,
        "duration": 3.551
    },
    {
        "text": "Just because ARS-853 is good at turning off\nmutant K-Ras doesn’t mean it’s the best",
        "start": 402.97,
        "duration": 4.81
    },
    {
        "text": "cancer treatment, though.",
        "start": 407.78,
        "duration": 1.389
    },
    {
        "text": "Even though it bound to the protein,",
        "start": 409.169,
        "duration": 1.191
    },
    {
        "text": "it was not potent enough to actually be effective\nwhen they tested it in mice.",
        "start": 410.36,
        "duration": 4.179
    },
    {
        "text": "So the same research team iterated on their\nmolecule again,",
        "start": 414.539,
        "duration": 3.371
    },
    {
        "text": "trying to make a new version that is more\nspecific to the mutated K-Ras protein and",
        "start": 417.91,
        "duration": 4.37
    },
    {
        "text": "more effective at lower doses.",
        "start": 422.28,
        "duration": 1.84
    },
    {
        "text": "This time, instead of altering the molecular\nsubunits around the edges of Compound 12,",
        "start": 424.12,
        "duration": 4.54
    },
    {
        "text": "the team looked more closely at the subunits\nin the middle, called the scaffold.",
        "start": 428.66,
        "duration": 4.05
    },
    {
        "text": "They made a bunch of versions of the molecule\nand introduced it to cells with mutant K-Ras",
        "start": 432.71,
        "duration": 4.35
    },
    {
        "text": "proteins.",
        "start": 437.06,
        "duration": 1.0
    },
    {
        "text": "And after analyzing the new versions, they\nfound they could improve Compound 12",
        "start": 438.06,
        "duration": 3.34
    },
    {
        "text": "by swapping out part of its scaffold for a\nquinazoline core.",
        "start": 441.4,
        "duration": 3.48
    },
    {
        "text": "Quinazoline cores are a part of several cancer-fighting\ndrugs",
        "start": 444.88,
        "duration": 3.14
    },
    {
        "text": "approved in the U.S. before 2017,",
        "start": 448.02,
        "duration": 2.489
    },
    {
        "text": "so it made sense to try swapping it in.",
        "start": 450.509,
        "duration": 1.72
    },
    {
        "text": "It turned out that ARS-853, the previous molecule\nthey’d ruled out,",
        "start": 452.229,
        "duration": 4.101
    },
    {
        "text": "had an unusual core that was so specific that\nit was difficult to improve the molecule more.",
        "start": 456.33,
        "duration": 5.28
    },
    {
        "text": "So by switching it to a quinazoline core,\nthese newer molecules had more room to improve.",
        "start": 461.61,
        "duration": 4.63
    },
    {
        "text": "And out of several quinazoline-containing\nvarieties of the molecule,",
        "start": 466.24,
        "duration": 3.48
    },
    {
        "text": "a version they called ARS-1620 came out on\ntop.",
        "start": 469.72,
        "duration": 4.16
    },
    {
        "text": "This version not only attached to the cysteine\nat position 12",
        "start": 473.88,
        "duration": 3.08
    },
    {
        "text": "but also attached to another amino acid, histidine,\nthat’s also in the groove.",
        "start": 476.96,
        "duration": 4.9
    },
    {
        "text": "Specifically, an atom on the quinazoline core\nis reaching out",
        "start": 481.86,
        "duration": 2.97
    },
    {
        "text": "and holding onto the histidine, which shows\njust how important",
        "start": 484.83,
        "duration": 3.82
    },
    {
        "text": "that core is to the drug doing its job.",
        "start": 488.65,
        "duration": 2.68
    },
    {
        "text": "That extra bond means that the drug molecule\nstays attached",
        "start": 491.33,
        "duration": 3.03
    },
    {
        "text": "to the mutant protein in a more rigid, stubborn\nway.",
        "start": 494.36,
        "duration": 2.97
    },
    {
        "text": "The researchers tested ARS-1620 in spherical\ncell cultures",
        "start": 497.33,
        "duration": 3.869
    },
    {
        "text": "hat mimic the structure of a tumor.",
        "start": 501.199,
        "duration": 2.171
    },
    {
        "text": "The molecule stopped cells with G12C KRAS\nmutations,",
        "start": 503.37,
        "duration": 3.519
    },
    {
        "text": "while those without the mutation weren’t\naffected.",
        "start": 506.889,
        "duration": 2.891
    },
    {
        "text": "Then they tested the drug in mice with G12C\nK-Ras cancers,",
        "start": 509.78,
        "duration": 4.78
    },
    {
        "text": "compared to mice with other cancers, and found\nit slowed the growth of tumors in the first",
        "start": 514.56,
        "duration": 4.89
    },
    {
        "text": "group.",
        "start": 519.45,
        "duration": 1.0
    },
    {
        "text": "Their paper, published in 2018, was the first\nto describe a molecule",
        "start": 520.45,
        "duration": 3.56
    },
    {
        "text": "that could not only specifically block mutant\nK-Ras proteins from causing trouble,",
        "start": 524.01,
        "duration": 4.54
    },
    {
        "text": "but also be taken orally by real, living animals",
        "start": 528.55,
        "duration": 3.27
    },
    {
        "text": "and shrink tumors without causing serious\nside effects.",
        "start": 531.82,
        "duration": 3.31
    },
    {
        "text": "After this, two other biotechnology companies,",
        "start": 535.13,
        "duration": 2.44
    },
    {
        "text": "Amgen Research and Mirati Therapeutics Inc.",
        "start": 537.57,
        "duration": 3.43
    },
    {
        "text": "picked up where Wellspring Biosciences left\noff.",
        "start": 541.0,
        "duration": 2.79
    },
    {
        "text": "Amgen researchers created a collection of\nnew molecules based on ARS-1620,",
        "start": 543.79,
        "duration": 4.96
    },
    {
        "text": "and then used advanced X-ray crystallography",
        "start": 548.75,
        "duration": 2.149
    },
    {
        "text": "to see how their molecules interacted with\nG12C K-Ras proteins.",
        "start": 550.899,
        "duration": 4.321
    },
    {
        "text": "And they found that when they added a new\naromatic ring,",
        "start": 555.22,
        "duration": 2.33
    },
    {
        "text": "which is this hexagon, to the quinazoline\ncore, the molecule could wedge itself into",
        "start": 557.55,
        "duration": 4.479
    },
    {
        "text": "another groove on the G12C K-Ras protein,\nright next to the histidine.",
        "start": 562.029,
        "duration": 4.581
    },
    {
        "text": "That new aromatic ring made Amgen’s molecule",
        "start": 566.61,
        "duration": 2.241
    },
    {
        "text": "about ten times better at holding onto the\nmutated K-Ras protein and keeping it inactive.",
        "start": 568.851,
        "duration": 5.379
    },
    {
        "text": "They named this molecule AMG 510.",
        "start": 574.23,
        "duration": 2.72
    },
    {
        "text": "AMG 510 was able to stop growth",
        "start": 576.95,
        "duration": 2.47
    },
    {
        "text": "and start tumor regression in mice with human\ntumor grafts",
        "start": 579.42,
        "duration": 3.05
    },
    {
        "text": "with a lower dose than the Wellspring Biosciences\nmolecule.",
        "start": 582.47,
        "duration": 3.3
    },
    {
        "text": "Mirati Therapeutics’ molecule, MRTX849,\nalso binds to the mutant cysteine,",
        "start": 585.77,
        "duration": 5.19
    },
    {
        "text": "plus a few other amino acids: A glycine at\nposition 10 on the mutant protein,",
        "start": 590.96,
        "duration": 3.819
    },
    {
        "text": "and a glutamic acid at position 62.",
        "start": 594.779,
        "duration": 2.111
    },
    {
        "text": "By 2020, all three companies showed that their\ndrug candidates",
        "start": 596.89,
        "duration": 3.49
    },
    {
        "text": "could shrink tumors in mice by targeting the\ngroove on G12C K-Ras proteins.",
        "start": 600.38,
        "duration": 4.71
    },
    {
        "text": "Mirati and Amgen started testing their drug\ncandidates in humans,",
        "start": 605.09,
        "duration": 3.59
    },
    {
        "text": "marking the end of experimental development\nand the beginning of clinical trials.",
        "start": 608.68,
        "duration": 4.339
    },
    {
        "text": "Clinical trials are necessary because there\nare a lot of differences between humans and",
        "start": 613.019,
        "duration": 3.271
    },
    {
        "text": "mice —",
        "start": 616.29,
        "duration": 1.0
    },
    {
        "text": "enough differences that drugs that work well\nin mice might not work at all,",
        "start": 617.29,
        "duration": 3.53
    },
    {
        "text": "or even cause problems, when given to humans.",
        "start": 620.82,
        "duration": 2.31
    },
    {
        "text": "When Amgen tested their drug in four people\nwith lung cancer,",
        "start": 623.13,
        "duration": 2.89
    },
    {
        "text": "two of them had their tumors shrink.",
        "start": 626.02,
        "duration": 1.86
    },
    {
        "text": "After six weeks of treatment, one participant\nwho was assigned a lower dose of AMG 510",
        "start": 627.88,
        "duration": 4.9
    },
    {
        "text": "had their tumor shrink by 34 percent,",
        "start": 632.78,
        "duration": 2.15
    },
    {
        "text": "and one with a higher dose had their tumor\nshrink by 67 percent.",
        "start": 634.93,
        "duration": 3.65
    },
    {
        "text": "About half of patients treated in early trials",
        "start": 638.58,
        "duration": 2.04
    },
    {
        "text": "with Amgen or Mirati Therapeutics’ drugs\nalso saw their tumors shrink.",
        "start": 640.62,
        "duration": 4.27
    },
    {
        "text": "In January of 2021, Amgen announced",
        "start": 644.89,
        "duration": 2.12
    },
    {
        "text": "they had enrolled 126 patients in another\ntrial,",
        "start": 647.01,
        "duration": 3.62
    },
    {
        "text": "and over a third responded to the treatment",
        "start": 650.63,
        "duration": 2.04
    },
    {
        "text": "with an average tumor regression of 60 percent.",
        "start": 652.67,
        "duration": 2.53
    },
    {
        "text": "And in May of 2021,",
        "start": 655.2,
        "duration": 1.98
    },
    {
        "text": "ARS-510 was approved under the name sotorasib\nby the U.S. FDA",
        "start": 657.18,
        "duration": 4.17
    },
    {
        "text": "for people with non-small cell lung cancer",
        "start": 661.35,
        "duration": 2.38
    },
    {
        "text": "with a KRAS mutation who didn’t respond\nto first-line treatments",
        "start": 663.73,
        "duration": 3.81
    },
    {
        "text": "like chemotherapy and immunotherapy.",
        "start": 667.54,
        "duration": 2.19
    },
    {
        "text": "Which is honestly amazing news.",
        "start": 669.73,
        "duration": 2.64
    },
    {
        "text": "It has been 40 years since the G12C mutation\nin KRAS was linked to cancer,",
        "start": 672.37,
        "duration": 5.37
    },
    {
        "text": "and 9 years since the breakthrough discovery",
        "start": 677.74,
        "duration": 2.48
    },
    {
        "text": "of a small groove on the surface of an otherwise\nsuper-smooth protein.",
        "start": 680.22,
        "duration": 4.66
    },
    {
        "text": "But it goes to show that no matter how long\nit takes,",
        "start": 684.88,
        "duration": 2.87
    },
    {
        "text": "thorough R&D is vital to making effective\nand safe new medications.",
        "start": 687.75,
        "duration": 4.13
    },
    {
        "text": "And as more, different drugs are designed\nto target this kind of cancer,",
        "start": 691.88,
        "duration": 4.19
    },
    {
        "text": "people will have more options to find the\nmedication that works best for them.",
        "start": 696.07,
        "duration": 4.639
    },
    {
        "text": "So, the science continues.",
        "start": 700.709,
        "duration": 2.111
    },
    {
        "text": "Thanks for watching this episode of SciShow!",
        "start": 702.82,
        "duration": 8.37
    },
    {
        "text": "And thank you to today’s sponsor,",
        "start": 711.19,
        "duration": 3.85
    },
    {
        "text": "Magic Spoon.",
        "start": 715.04,
        "duration": 1.0
    },
    {
        "text": "They have best-selling cereal flavors full\nof childhood nostalgia,",
        "start": 716.04,
        "duration": 3.07
    },
    {
        "text": "like Cocoa, Fruity, Frosted, and Peanut Butter.",
        "start": 719.11,
        "duration": 2.87
    },
    {
        "text": "But you know what it’s not full of?",
        "start": 721.98,
        "duration": 1.56
    },
    {
        "text": "Sugar.",
        "start": 723.54,
        "duration": 1.0
    },
    {
        "text": "Magic spoon has 0 grams of sugar, 14 grams\nof protein,",
        "start": 724.54,
        "duration": 3.161
    },
    {
        "text": "and only 4 net grams of carbs in each serving;",
        "start": 727.701,
        "duration": 2.869
    },
    {
        "text": "it’s also only 140 calories.",
        "start": 730.57,
        "duration": 2.25
    },
    {
        "text": "So it’s super tasty and great for different\ndietary needs,",
        "start": 732.82,
        "duration": 3.449
    },
    {
        "text": "like if you’re gluten-free.",
        "start": 736.269,
        "duration": 1.081
    },
    {
        "text": "If you want to bring out your inner child\nand grab a variety pack,",
        "start": 737.35,
        "duration": 3.09
    },
    {
        "text": "click the link below or go to magicspoon.com/SciShow.",
        "start": 740.44,
        "duration": 3.17
    },
    {
        "text": "You can use the promo code [SciShow] at checkout\nto get $5 off any order.",
        "start": 743.61,
        "duration": 4.02
    },
    {
        "text": "Plus, your order is backed with a 100% happiness\nguarantee,",
        "start": 747.63,
        "duration": 3.09
    },
    {
        "text": "so if you don’t like it for any reason,\nthey'll refund your money, no questions asked.",
        "start": 750.72,
        "duration": 4.85
    },
    {
        "text": "Thanks again for watching!",
        "start": 755.57,
        "duration": 0.732
    },
    {
        "text": "[♪ OUTRO]",
        "start": 756.302,
        "duration": 9.963
    }
]